Filter
796
Filtered Results: 796
Text search:
TB
panel
Featured
Recommendations
80
New Publications
228
Language
Document type
No document type
482
Guidelines
117
Studies & Reports
116
Manuals
37
Strategic & Response Plan
24
Training Material
8
Situation Updates
5
Fact sheets
4
Brochures
2
Infographics
1
Countries / Regions
India
65
Global
26
Western and Central Europe
23
Africa
22
Uganda
18
South Africa
17
Latin America and the Carribbean
16
Ethiopia
15
Eastern Europe
13
Nepal
11
Kenya
11
Nigeria
11
Malawi
11
Liberia
11
Argentina
10
Asia
9
South–East Asia Region
9
Zambia
9
Sierra Leone
8
Tanzania
8
Colombia
7
Lesotho
7
Senegal
7
Philippines
7
Namibia
7
Myanmar / Burma
7
Ukraine
6
Peru
6
East and Southern Africa
6
Cambodia
5
Rwanda
4
Congo, Democratic Republic of
4
West and Central Africa
4
Middle East and North Africa
4
Paraguay
4
Bangladesh
4
Russia
4
South Sudan
4
Ghana
3
Albania
3
Guinea
3
Mozambique
3
Brazil
3
Angola
3
Indonesia
3
Thailand
2
El Salvador
2
Syria
2
Burkina Faso
2
Afghanistan
2
Zimbabwe
2
Guinea-Bissau
2
Venezuela
2
Jordan
2
Germany
2
Eastern Europe and Central Asia
2
Southern Africa
2
Bolivia
2
Vietnam
2
Sri Lanka
2
Ecuador
2
Eswatini/ Swaziland
2
Pakistan
2
Timor Leste/ East Timor
1
Benin
1
Chile
1
Cameroon
1
Laos
1
USA
1
Haiti
1
Dominican Republic
1
North America
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Yemen
1
Georgia
1
Honduras
1
Chad
1
Bhutan
1
Botswana
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
296
Clinical Guidelines
94
Public Health
30
Women & Child Health
29
Pharmacy & Technologies
18
Key Resources
13
Capacity Building
9
Toolboxes
TB
184
HIV
110
COVID-19
36
AMR
35
Pharmacy
24
NTDs
24
Mental Health
16
Health Financing Toolbox
16
Global Health Education
16
Caregiver
14
Planetary Health
11
Disability
9
Ebola
9
Refugee
8
NCDs
7
Polio
6
Rapid Response
5
Conflict
5
Natural Hazards
2
Cholera
1
Social Ethics
1
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Sector Environmental Guidelines, Full technical Update
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Este manual se ha elaborado en el marco de la Iniciativa Global de la Organización Mundial de la Salud (OMS) para el Cáncer Infantil, CureAll Americas, con el propósito de mejorar la situación de los niños, niñas y adolescentes con cáncer en todo el mundo, para que puedan tener las mejores po...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
The Sustainable Development Goals (SDGs) call for major societal transformations that will require significant fiscal outlays as well as private investments. The fiscal outlays cover public investments, the public provision of social services, and social protection for vulnerable populations. The ke...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
There is growing understanding and high-level endorsement of the importance of strong collaborative multisectoral approaches to address a broad range of social, economic and governance issues for the prevention and control of noncommunicable disease (NCDs) and mental health conditions. In 2019, Worl...
The world is off track to make significant progress towards universal health coverage (UHC) (SDG target 3.8) by 2030 as improvements to health services coverage have stagnated since 2015, and the proportion of the population that faced catastrophic levels of out-of-pocket (OOP) health spending has i...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
